nodes	percent_of_prediction	percent_of_DWPC	metapath
Antazoline—Benzphetamine—obesity	0.56	1	CrCtD
Antazoline—Ditazole—Benzphetamine—obesity	0.0515	0.123	CrCrCtD
Antazoline—Tolazoline—Phentermine—obesity	0.035	0.0838	CrCrCtD
Antazoline—Trimethaphan—Benzphetamine—obesity	0.0317	0.0759	CrCrCtD
Antazoline—Tolazoline—Methamphetamine—obesity	0.0312	0.0747	CrCrCtD
Antazoline—Bepridil—Benzphetamine—obesity	0.0248	0.0592	CrCrCtD
Antazoline—Monobenzone—Benzphetamine—obesity	0.0214	0.0512	CrCrCtD
Antazoline—Oxaprozin—Benzphetamine—obesity	0.0214	0.0512	CrCrCtD
Antazoline—Phenytoin—Benzphetamine—obesity	0.0214	0.0512	CrCrCtD
Antazoline—Naftifine—Benzphetamine—obesity	0.0205	0.049	CrCrCtD
Antazoline—Alverine—Benzphetamine—obesity	0.0197	0.047	CrCrCtD
Antazoline—Phenoxybenzamine—Benzphetamine—obesity	0.0135	0.0323	CrCrCtD
Antazoline—Dextropropoxyphene—Benzphetamine—obesity	0.0135	0.0323	CrCrCtD
Antazoline—Diphenidol—Benzphetamine—obesity	0.0135	0.0323	CrCrCtD
Antazoline—Tripelennamine—Benzphetamine—obesity	0.0129	0.0308	CrCrCtD
Antazoline—Modafinil—Benzphetamine—obesity	0.0126	0.0301	CrCrCtD
Antazoline—Fentanyl—Benzphetamine—obesity	0.012	0.0287	CrCrCtD
Antazoline—Benzphetamine—Methamphetamine—obesity	0.0119	0.0285	CrCrCtD
Antazoline—Cyclizine—Benzphetamine—obesity	0.0115	0.0276	CrCrCtD
Antazoline—Methadone—Benzphetamine—obesity	0.0113	0.027	CrCrCtD
Antazoline—Clofedanol—Benzphetamine—obesity	0.00976	0.0233	CrCrCtD
Antazoline—Benzyl Benzoate—Benzphetamine—obesity	0.00876	0.0209	CrCrCtD
Antazoline—Diphenhydramine—Benzphetamine—obesity	0.00839	0.0201	CrCrCtD
Antazoline—Trimethaphan—BCHE—obesity	0.00018	0.309	CrCbGaD
Antazoline—Phenoxybenzamine—SLC22A1—obesity	9.58e-05	0.164	CrCbGaD
Antazoline—Diphenhydramine—SLC22A1—obesity	8.03e-05	0.138	CrCbGaD
Antazoline—Oxaprozin—PTGS2—obesity	7.63e-05	0.131	CrCbGaD
Antazoline—Phenoxybenzamine—ADRB2—obesity	6.11e-05	0.105	CrCbGaD
Antazoline—Methadone—CYP19A1—obesity	5.76e-05	0.099	CrCbGaD
Antazoline—HRH1—GPCR downstream signaling—NMU—obesity	3.44e-05	0.0016	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HCRT—obesity	3.44e-05	0.0016	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PMCH—obesity	3.44e-05	0.0016	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—obesity	3.39e-05	0.00158	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—obesity	3.39e-05	0.00158	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—KIF7—obesity	3.37e-05	0.00157	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MKS1—obesity	3.37e-05	0.00157	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—NPS—obesity	3.35e-05	0.00156	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—MC3R—obesity	3.3e-05	0.00153	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—MC4R—obesity	3.3e-05	0.00153	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—NPY1R—obesity	3.3e-05	0.00153	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—NPY2R—obesity	3.3e-05	0.00153	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—DRD1—obesity	3.29e-05	0.00153	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HTR2C—obesity	3.29e-05	0.00153	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PPY—obesity	3.24e-05	0.00151	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—ADRB1—obesity	3.18e-05	0.00148	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GIP—obesity	3.18e-05	0.00148	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PRKCH—obesity	3.18e-05	0.00148	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—obesity	3.14e-05	0.00146	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NPY5R—obesity	3.12e-05	0.00145	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NMU—obesity	3.12e-05	0.00145	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HCRT—obesity	3.12e-05	0.00145	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PMCH—obesity	3.12e-05	0.00145	CbGpPWpGaD
Antazoline—Phenytoin—ALB—obesity	3.12e-05	0.0536	CrCbGaD
Antazoline—HRH1—GPCR ligand binding—GHRL—obesity	3.12e-05	0.00145	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—obesity	3.09e-05	0.00144	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—DRD4—obesity	3.09e-05	0.00144	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRLH—obesity	3.08e-05	0.00143	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—obesity	3e-05	0.0014	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—MC3R—obesity	3e-05	0.00139	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—MC4R—obesity	3e-05	0.00139	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NPY2R—obesity	3e-05	0.00139	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NPY1R—obesity	3e-05	0.00139	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CNR1—obesity	2.95e-05	0.00137	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PPY—obesity	2.94e-05	0.00137	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GIP—obesity	2.88e-05	0.00134	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PRKCH—obesity	2.88e-05	0.00134	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—DRD2—obesity	2.88e-05	0.00134	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—GCG—obesity	2.85e-05	0.00133	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—PIK3R1—obesity	2.79e-05	0.0013	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADRB3—obesity	2.7e-05	0.00126	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—obesity	2.65e-05	0.00123	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—obesity	2.65e-05	0.00123	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GAL—obesity	2.64e-05	0.00123	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—C5AR1—obesity	2.61e-05	0.00121	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—ADRB2—obesity	2.58e-05	0.0012	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GHRH—obesity	2.55e-05	0.00119	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NMB—obesity	2.55e-05	0.00119	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—obesity	2.54e-05	0.00118	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—obesity	2.51e-05	0.00117	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—obesity	2.49e-05	0.00116	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—GNB3—obesity	2.46e-05	0.00114	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADRB3—obesity	2.45e-05	0.00114	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FFAR4—obesity	2.44e-05	0.00113	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GAL—obesity	2.4e-05	0.00111	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—GNAS—obesity	2.39e-05	0.00111	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCK—obesity	2.39e-05	0.00111	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—C5AR1—obesity	2.37e-05	0.0011	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—BRS3—obesity	2.34e-05	0.00109	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MCHR1—obesity	2.34e-05	0.00109	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GHSR—obesity	2.34e-05	0.00109	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GLP1R—obesity	2.32e-05	0.00108	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—obesity	2.32e-05	0.00108	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCL5—obesity	2.29e-05	0.00106	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCKAR—obesity	2.29e-05	0.00106	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HRH3—obesity	2.29e-05	0.00106	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GH1—obesity	2.17e-05	0.00101	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SH2B1—obesity	2.17e-05	0.00101	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRLHR—obesity	2.17e-05	0.00101	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCK—obesity	2.17e-05	0.00101	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—obesity	2.12e-05	0.000984	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GLP1R—obesity	2.11e-05	0.000982	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCKAR—obesity	2.08e-05	0.000966	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HRH3—obesity	2.08e-05	0.000966	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—NPY—obesity	2.07e-05	0.000964	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—obesity	2.07e-05	0.000963	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—IAPP—obesity	2.06e-05	0.000958	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APLN—obesity	2.04e-05	0.00095	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PYY—obesity	2.04e-05	0.00095	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HTR2A—obesity	2.02e-05	0.000938	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—C3—obesity	2.01e-05	0.000937	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PRKAR2B—obesity	2e-05	0.00093	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR1B—obesity	2e-05	0.00093	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CRH—obesity	2e-05	0.00093	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PNLIP—obesity	1.94e-05	0.0009	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—AGT—obesity	1.91e-05	0.00089	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—NPS—obesity	1.89e-05	0.000882	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SDC3—obesity	1.89e-05	0.000879	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NPY—obesity	1.88e-05	0.000875	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IAPP—obesity	1.87e-05	0.00087	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—DRD1—obesity	1.86e-05	0.000865	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR2C—obesity	1.86e-05	0.000865	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HCRT—obesity	1.85e-05	0.000859	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NMU—obesity	1.85e-05	0.000859	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPY5R—obesity	1.85e-05	0.000859	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PMCH—obesity	1.85e-05	0.000859	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR1B—obesity	1.82e-05	0.000844	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CRH—obesity	1.82e-05	0.000844	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADRB1—obesity	1.8e-05	0.000837	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPY2R—obesity	1.77e-05	0.000823	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MC4R—obesity	1.77e-05	0.000823	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPY1R—obesity	1.77e-05	0.000823	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MC3R—obesity	1.77e-05	0.000823	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—F2—obesity	1.77e-05	0.000823	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GHRL—obesity	1.76e-05	0.00082	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—DRD4—obesity	1.75e-05	0.000813	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PPY—obesity	1.74e-05	0.000807	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NPS—obesity	1.72e-05	0.000801	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRKCH—obesity	1.7e-05	0.000793	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HDAC8—obesity	1.7e-05	0.000793	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GIP—obesity	1.7e-05	0.000793	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DRD1—obesity	1.69e-05	0.000785	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR2C—obesity	1.69e-05	0.000785	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CNR1—obesity	1.67e-05	0.000776	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADRB1—obesity	1.63e-05	0.00076	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—DRD2—obesity	1.63e-05	0.000757	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—LEPR—obesity	1.62e-05	0.000753	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GCG—obesity	1.61e-05	0.00075	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—POMC—obesity	1.61e-05	0.000749	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GHRL—obesity	1.6e-05	0.000744	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DRD4—obesity	1.59e-05	0.000738	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCL2—obesity	1.58e-05	0.000733	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—PIK3CA—obesity	1.57e-05	0.000729	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CNR1—obesity	1.51e-05	0.000705	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DRD2—obesity	1.48e-05	0.000688	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GCG—obesity	1.46e-05	0.000681	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADRB2—obesity	1.46e-05	0.000678	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADRB3—obesity	1.45e-05	0.000674	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GAL—obesity	1.41e-05	0.000658	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—obesity	1.4e-05	0.000652	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—C5AR1—obesity	1.4e-05	0.000651	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GNB3—obesity	1.39e-05	0.000646	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GNAS—obesity	1.35e-05	0.000629	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADRB2—obesity	1.32e-05	0.000616	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCL5—obesity	1.29e-05	0.000602	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCK—obesity	1.28e-05	0.000595	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRKG1—obesity	1.28e-05	0.000595	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GNB3—obesity	1.26e-05	0.000587	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RBP4—obesity	1.25e-05	0.00058	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GLP1R—obesity	1.25e-05	0.00058	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—obesity	1.24e-05	0.000578	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GNAS—obesity	1.23e-05	0.000571	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCKAR—obesity	1.23e-05	0.000571	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HRH3—obesity	1.23e-05	0.000571	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRKAR2B—obesity	1.18e-05	0.000549	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL5—obesity	1.17e-05	0.000546	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PRKCD—obesity	1.16e-05	0.000542	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NCF2—obesity	1.14e-05	0.000531	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR2A—obesity	1.14e-05	0.00053	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—C3—obesity	1.14e-05	0.00053	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPY—obesity	1.11e-05	0.000517	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOC3—obesity	1.1e-05	0.000514	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IAPP—obesity	1.1e-05	0.000514	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AGT—obesity	1.08e-05	0.000503	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR1B—obesity	1.07e-05	0.000499	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CRH—obesity	1.07e-05	0.000499	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SDC1—obesity	1.06e-05	0.000493	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PRKCD—obesity	1.06e-05	0.000492	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AKR1C3—obesity	1.04e-05	0.000485	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR2A—obesity	1.04e-05	0.000482	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—C3—obesity	1.03e-05	0.000481	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPS—obesity	1.02e-05	0.000473	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—F2—obesity	9.99e-06	0.000465	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PRKCB—obesity	9.99e-06	0.000465	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DRD1—obesity	9.97e-06	0.000464	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR2C—obesity	9.97e-06	0.000464	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AGT—obesity	9.82e-06	0.000457	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NTRK2—obesity	9.7e-06	0.000451	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADRB1—obesity	9.65e-06	0.000449	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PIK3CG—obesity	9.56e-06	0.000445	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PARP1—obesity	9.45e-06	0.00044	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GHRL—obesity	9.45e-06	0.00044	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DRD4—obesity	9.37e-06	0.000436	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—POMC—obesity	9.1e-06	0.000424	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—F2—obesity	9.08e-06	0.000422	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PRKCB—obesity	9.08e-06	0.000422	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CNR1—obesity	8.95e-06	0.000416	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TCF7L2—obesity	8.79e-06	0.000409	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AKT2—obesity	8.75e-06	0.000407	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DRD2—obesity	8.73e-06	0.000406	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PIK3CG—obesity	8.69e-06	0.000404	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GCG—obesity	8.64e-06	0.000402	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PTPN1—obesity	8.64e-06	0.000402	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PIK3CD—obesity	8.41e-06	0.000391	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—POMC—obesity	8.27e-06	0.000385	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRL—obesity	8.25e-06	0.000384	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—STK11—obesity	8.13e-06	0.000378	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL2—obesity	8.09e-06	0.000376	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PLG—obesity	8.04e-06	0.000374	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—RHOA—obesity	8.02e-06	0.000373	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AKT2—obesity	7.95e-06	0.00037	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PIK3R1—obesity	7.94e-06	0.000369	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FOXO3—obesity	7.84e-06	0.000365	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADRB2—obesity	7.82e-06	0.000364	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SOCS1—obesity	7.7e-06	0.000358	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PIK3CD—obesity	7.64e-06	0.000355	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SOCS3—obesity	7.61e-06	0.000354	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GNB3—obesity	7.45e-06	0.000347	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—TYK2—obesity	7.35e-06	0.000342	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PIK3CB—obesity	7.33e-06	0.000341	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IGF2—obesity	7.32e-06	0.00034	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—RHOA—obesity	7.28e-06	0.000339	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GNAS—obesity	7.25e-06	0.000337	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PIK3R1—obesity	7.21e-06	0.000335	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOB—obesity	7.1e-06	0.00033	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL5—obesity	6.94e-06	0.000323	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—LPL—obesity	6.78e-06	0.000316	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FOXO1—obesity	6.73e-06	0.000313	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RPS6KB1—obesity	6.72e-06	0.000313	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PIK3CB—obesity	6.66e-06	0.00031	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRKCD—obesity	6.25e-06	0.000291	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR2A—obesity	6.12e-06	0.000284	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—C3—obesity	6.11e-06	0.000284	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IRS2—obesity	5.81e-06	0.00027	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AGT—obesity	5.8e-06	0.00027	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—LEP—obesity	5.69e-06	0.000264	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOE—obesity	5.69e-06	0.000264	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CAV1—obesity	5.63e-06	0.000262	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOA1—obesity	5.62e-06	0.000261	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ESR1—obesity	5.43e-06	0.000253	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRKCB—obesity	5.36e-06	0.000249	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—F2—obesity	5.36e-06	0.000249	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—BAD—obesity	5.3e-06	0.000246	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PIK3CG—obesity	5.13e-06	0.000239	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IRS1—obesity	5.07e-06	0.000236	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—POMC—obesity	4.88e-06	0.000227	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—INS—obesity	4.86e-06	0.000226	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL2—obesity	4.78e-06	0.000222	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IGF1—obesity	4.7e-06	0.000219	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AKT2—obesity	4.69e-06	0.000218	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PIK3CD—obesity	4.51e-06	0.00021	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PIK3CA—obesity	4.47e-06	0.000208	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SERPINE1—obesity	4.46e-06	0.000208	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TYK2—obesity	4.34e-06	0.000202	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RHOA—obesity	4.3e-06	0.0002	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PIK3R1—obesity	4.26e-06	0.000198	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NOS3—obesity	4.26e-06	0.000198	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PIK3CA—obesity	4.06e-06	0.000189	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MTOR—obesity	3.93e-06	0.000183	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PIK3CB—obesity	3.93e-06	0.000183	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AKT1—obesity	3.65e-06	0.00017	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IL6—obesity	3.59e-06	0.000167	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MMP9—obesity	3.42e-06	0.000159	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MAPK8—obesity	3.32e-06	0.000155	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AKT1—obesity	3.31e-06	0.000154	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—STAT3—obesity	3.04e-06	0.000141	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MYC—obesity	2.82e-06	0.000131	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TGFB1—obesity	2.82e-06	0.000131	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PIK3CA—obesity	2.4e-06	0.000111	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IL6—obesity	2.12e-06	9.87e-05	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AKT1—obesity	1.96e-06	9.11e-05	CbGpPWpGaD
